Bessemer Group
BSTC

Bessemer Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bessemer Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,711
Closed -$1.27M – 1791
2020
Q2 		$1.27M Buy
20,711
+16,800
+430% +$972K ﹤0.01% 645
2020
Q1 		$221K Buy
+3,911
New +$223K ﹤0.01% 968
2016
Q2 		– Sell
-33
Closed -$1K – 1511
2016
Q1 		$1K Buy
+33
New +$1.21K ﹤0.01% 1448

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Bessemer Group's BSTC Position: Q3 2020 in Review

Bessemer Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 20,711 shares — an estimated $1.27M sold.

Bessemer Group first reported a position in BSTC in Q1 2016 and held it in 3 quarters. The position peaked at $1.27M in Q2 2020. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • Bessemer Group reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • Bessemer Group sold 20,711 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $1.27M.
  • Bessemer Group first reported a position in BioSpecifics Technologies Corp. in Q1 2016 and held it in 3 quarters.
  • Bessemer Group's BioSpecifics Technologies Corp. position peaked at $1.27M in Q2 2020.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Bessemer Group's 13F filing for Q3 2020, filed 12 Nov 2020.